SCHEMBL20465191

SCHEMBL20465191

CCn1c(C(=O)c2ccc(C)cn2)cc2cc(C(=O)O)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.46
KDM4E B2RXH2 3/20 0.46
THRB P10828 3/20 0.46
MEN1 O00255 3/20 0.46
MAPT P10636 3/20 0.46
HPGD P15428 3/20 0.46
RAB9A P51151 2/20 0.46
GPR35 Q9HC97 2/20 0.41
ALDH1A1 P00352 2/20 0.40
HCAR3 P49019 1/20 0.39
PTGER4 P35408 3/20 0.39
GAA P10253 2/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
PABPC1 P11940 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20465188 0.88 RAB9A (0.47) KMT2AKDM4EMEN1MAPTHPGD
SCHEMBL18440690 0.86 RORC (0.45) KMT2AKDM4EGPR35ALDH1A1ACSS2
SCHEMBL18440902 0.76 RAB9A (0.43) KMT2AKDM4EMEN1MAPTHPGD
SCHEMBL20465195 0.76 RORC (0.60)
SCHEMBL14549402 0.74 KMT2A (0.51) KMT2AKDM4ETHRBMEN1MAPT
SCHEMBL9613337 0.74 GPR35 (0.62) KMT2AKDM4ETHRBMEN1MAPT
SCHEMBL19360617 0.74 SRD5A2 (0.49) KMT2AKDM4EGPR35ALDH1A1ACSS2
SCHEMBL20465147 0.71 SRD5A2 (0.48) KMT2AKDM4ETHRBMEN1MAPT
SCHEMBL5889499 0.69 ALDH1A1 (0.56) KDM4EHPGDGPR35ALDH1A1HCAR3
SCHEMBL28219655 0.68 ALDH1A1 (0.48) KMT2AKDM4ETHRBMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180222860-A1 MODULATORS OF ROR-GAMMA VITAE PHARMACEUTICALS, LLC 2018-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180222860-A1 MODULATORS OF ROR-GAMMA RORB, RORC, RORA KMT2A 2604/4885KDM4E 3259/4885THRB 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.